132 related articles for article (PubMed ID: 28294511)
1. UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population.
De Mattia E; Cecchin E; Polesel J; Lupo F; Tiribelli C; Crovatto M; Buonadonna A; Toffoli G
Liver Int; 2017 Sep; 37(9):1345-1353. PubMed ID: 28294511
[TBL] [Abstract][Full Text] [Related]
2. Genetic biomarkers for hepatocellular cancer risk in a caucasian population.
De Mattia E; Cecchin E; Polesel J; Bignucolo A; Roncato R; Lupo F; Crovatto M; Buonadonna A; Tiribelli C; Toffoli G
World J Gastroenterol; 2017 Sep; 23(36):6674-6684. PubMed ID: 29085212
[TBL] [Abstract][Full Text] [Related]
3. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in japanese patients with hepatitis C virus infection.
Wang Y; Kato N; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Shiina S; Kawabe T; Ito YM; Omata M
Clin Cancer Res; 2004 Apr; 10(7):2441-6. PubMed ID: 15073122
[TBL] [Abstract][Full Text] [Related]
4. UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?
Stücker I; Loriot MA; N'koutchou G; Cénée S; Bodin L; Mulot C; Gelu-Simeon M; Pelletier L; Bronowicki JP; Degos F; Beaune P; Laurent-Puig P; Hémon D; Trinchet JC; Pelletier G
BMC Cancer; 2007 Nov; 7():214. PubMed ID: 18021430
[TBL] [Abstract][Full Text] [Related]
5. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
6. UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females.
Mercke Odeberg J; Andrade J; Holmberg K; Hoglund P; Malmqvist U; Odeberg J
Eur J Clin Pharmacol; 2006 Oct; 62(10):829-37. PubMed ID: 16909274
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population.
Liu Y; Sui J; Zhai L; Yang S; Huang L; Huang L; Mo C; Wu J; Li S; Qin X
Med Oncol; 2014 Oct; 31(10):200. PubMed ID: 25195037
[TBL] [Abstract][Full Text] [Related]
8. Association analysis of UGT1A genotype and haplotype with SN-38 glucuronidation in human livers.
Wang H; Bian T; Jin T; Chen Y; Lin A; Chen C
Pharmacogenomics; 2014 Apr; 15(6):785-98. PubMed ID: 24897286
[TBL] [Abstract][Full Text] [Related]
9. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.
Vogel A; Kneip S; Barut A; Ehmer U; Tukey RH; Manns MP; Strassburg CP
Gastroenterology; 2001 Nov; 121(5):1136-44. PubMed ID: 11677206
[TBL] [Abstract][Full Text] [Related]
10. UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers.
Kong SY; Ki CS; Yoo BC; Kim JW
Cancer Sci; 2008 Feb; 99(2):340-4. PubMed ID: 18271934
[TBL] [Abstract][Full Text] [Related]
11. Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations.
Maeda H; Hazama S; Shavkat A; Okamoto K; Oba K; Sakamoto J; Takahashi K; Oka M; Nakamura D; Tsunedomi R; Okayama N; Mishima H; Kobayashi M
Mol Diagn Ther; 2014 Jun; 18(3):333-42. PubMed ID: 24453052
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
[TBL] [Abstract][Full Text] [Related]
13. The influence of caveolin-1 gene polymorphisms on hepatitis B virus-related hepatocellular carcinoma susceptibility in Chinese Han population: A case-control study.
Zhang J; Xue F; Chen S; Zhang D; Lu C; Tang G
Medicine (Baltimore); 2017 Oct; 96(42):e7359. PubMed ID: 29049173
[TBL] [Abstract][Full Text] [Related]
14. Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.
Lu L; Zhou J; Shi J; Peng XJ; Qi XX; Wang Y; Li FY; Zhou FY; Liu L; Liu ZQ
PLoS One; 2015; 10(5):e0127524. PubMed ID: 26010150
[TBL] [Abstract][Full Text] [Related]
15. Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes.
Innocenti F; Liu W; Chen P; Desai AA; Das S; Ratain MJ
Pharmacogenet Genomics; 2005 May; 15(5):295-301. PubMed ID: 15864130
[TBL] [Abstract][Full Text] [Related]
16. DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients.
Borentain P; Gérolami V; Ananian P; Garcia S; Noundou A; Botta-Fridlund D; Le Treut YP; Bergé-Lefranc JL; Gérolami R
Eur J Cancer; 2007 Nov; 43(17):2479-86. PubMed ID: 17870518
[TBL] [Abstract][Full Text] [Related]
17. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
19. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.
Villeneuve L; Girard H; Fortier LC; Gagné JF; Guillemette C
J Pharmacol Exp Ther; 2003 Oct; 307(1):117-28. PubMed ID: 12944498
[TBL] [Abstract][Full Text] [Related]
20. Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis.
Liu D; Li J; Gao J; Li Y; Yang R; Shen L
BMC Cancer; 2017 Jun; 17(1):437. PubMed ID: 28637434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
